Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
21 studies found for:    Open Studies | "Rhinitis, Allergic, Seasonal"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Phase II Study of Grass Pollen Allergy Vaccine BM32
Condition: Grass Pollen Allergy
Interventions: Biological: BM32;   Biological: Placebo
2 Unknown  Observational Study With PASCALLERG ® in Patients With Hay Fever
Condition: Hay Fever
Intervention:
3 Not yet recruiting Efficacy and Safety of S0597 in Seasonal Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Placebo;   Drug: S0597 low dose;   Drug: S0597 mid dose;   Drug: S0597 high dose;   Drug: Reference
4 Recruiting To Study GSP 301 in Patients With Seasonal Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: GSP 301-1 NS;   Drug: GSP 301-2 NS;   Drug: Placebo nasal spray;   Drug: Olopatadine hydrochloride NS-1;   Drug: Olopatadine hydrochloride NS-2;   Drug: Mometasone furoate NS-1;   Drug: Mometasone furoate NS-2
5 Recruiting Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Desloratadine 5 mg;   Drug: Placebo
6 Recruiting Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Ciclesonide;   Drug: Ciclesonide Placebo
7 Unknown  Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: montelukast;   Drug: cetirizine;   Drug: montelukast and cetirizine;   Drug: placebo
8 Recruiting Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Azelastine Hydrochloride/Fluticasone Propionate Nasal Spray;   Drug: Placebo nasal spray
9 Unknown  Optimal Concentration of Dermatophagoides Pteronyssinus (Dp) Allergen Extract for Skin Prick Test (SPT) of Thai Population
Conditions: Rhinitis, Allergic, Perennial;   Rhinitis, Allergic, Seasonal;   Skin Prick Test
Intervention:
10 Not yet recruiting Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Nasapaque Nasal Solution;   Drug: Placebo Saline Nasal Solution
11 Recruiting Contac Bien Z Adverse Effect Survey
Conditions: Allergic Rhinitis;   Seasonal Allergic Rhinitis
Intervention: Other: Cetrizine hydrochloride
12 Recruiting Allergic Rhinitis Changes the Sinus Microbiome
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: QNASL;   Drug: Placebo nasal spray
13 Recruiting Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Azelastine hydrochloride and Fluticasone propionate;   Drug: Dymista™;   Other: Placebo
14 Not yet recruiting Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Other: Grass pollen sublingual immunotherapy tablet;   Drug: Control
15 Not yet recruiting Effect of the Nasal Provocation on the Breathing Style
Conditions: Birch Pollen Allergy;   Healthy Control Subjects
Intervention: Biological: 1. session birch pollen nasal exposure 2. session xylometazoline nasal exposure
16 Unknown  Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy
Conditions: Birch Pollen Related Apple Allergy;   Birch Pollen Allergy
Interventions: Drug: rMal d 1;   Drug: rBet v 1;   Other: placebo drops
17 Unknown  A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
Conditions: Allergic Rhinitis;   Allergic Conjunctivitis
Interventions: Biological: modified allergen extract;   Biological: Placebo
18 Unknown  Efficacy and Safety of Sublingual Immunotherapy (SLIT)
Condition: Allergic Rhinitis
Interventions: Biological: sublingual immunotherapy with allergen extract;   Biological: sublingual immunotherapy with placebo
19 Recruiting Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study
Condition: Allergic Rhinitis
Interventions: Drug: Grazax;   Drug: Grazax Placebo
20 Recruiting Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen
Conditions: Allergic Rhinitis;   Asthma;   Latent Tuberculosis
Interventions: Other: TLR Agonist;   Other: Tuberculin nasal challenge;   Other: Timothy Grass Pollen

   Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results    Last Page
Indicates status has not been verified in more than two years